intestinal permeability and mucosal healing
NICE obesity guidance (CG189) recommends multicomponent interventions addressing diet, physical activity, and behaviour change as first-line management
Many chronic conditions persist not because the original injury was severe, but because the inflammatory response never properly resolved
Interestingly, the total amounts of these proteins appeared to have remained unchanged, leading to the speculation that BPC-157s role might be more about activating existing molecules rather than increasing their production
Peptide therapies like AOD9604 or tesamorelin can play a complementary role in bodycomposition and metabolic wellness, but outside of tesamorelins HIV indication, their weightloss evidence base is smaller and they should be framed as adjunctive tools rather than replacements for wellstudied GLP1 treatments
BPC-157 BPC-157 is a synthetic peptide derived from bovine intestinal mucosa, originally identified for its potential biological effects in the gastrointestinal and musculoskeletal systems
